Yes Toniv, I agree an update from Zenith is long overdue. The link on their website to the May 13, 2015 corporate update doesn't work anymore. However, I recall it was a very good presentation that highlighted their progress with their lead compounds in cancer and atuoimmune diseases. Masila did post a transcript from the June 30th Zenith special meeting that had some interesting info. And Zenith is presenting at the AACR meeting in Boston next Sunday, Nov 8th. The abstract is in that link and is very encouraging. Zenith AGM is rumored to be December 21st. And as far as we've been told, they are still targeting the second half of 2015 to file an IND for hematological malignancies and solid tumors. That's all I've got for ya.

BDAZ